NAHL Group (NAH) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
12 Oct, 2026Executive summary
H1 revenue was £19.2m; underlying operating profit rose 74% to £3.2m and profit before tax rose 289% to £1.9m.
Strong cash generation reduced net debt to £5.6m at 30 June 2025, a 10-year low and 38% below June 2024.
Personal Injury recovery and Critical Care growth supported earnings, while panel enquiries and case management demand remained weak.
Financial highlights
Revenue was £19.2m versus £19.4m; statutory operating profit was £3.0m, underlying PBT £2.1m and statutory PBT £1.9m.
Profit for the period was £1.4m versus £0.3m; basic underlying EPS rose to 3.0p from 0.7p, up 323%.
Free cash flow rose 119% to £1.5m; underlying operating cash generated was £3.2m, with 102% cash conversion.
H1 results included £0.2m of exceptional costs.
Outlook and guidance
The Board remained confident of delivering full-year results in line with market expectations.
July–August Consumer Legal Services enquiries were 2,452, 12% above the H1 monthly average and at lower average acquisition cost; NAL settlement cash was £1.5m versus £1.4m YoY.
Net debt fell to £5.5m at 31 August 2025 from £5.6m at 30 June.
July–August Critical Care activity included 230 expert witness reports and 81 INA reports; expert witness instructions rose 6%, while case management instructions fell 30%.
Latest events from NAHL Group
- Q2 momentum held as Bush & Co sale talks ended and alternatives were explored.NAH
AGM 2025 - Strong cash generation offset Personal Injury weakness as Critical Care grew.NAH
Trading update - Net debt fell 7%, Bush & Co. grew double digits, and full-year expectations were maintained.NAH
Trading update - FY25 profit and cash generation surged, but lower NAL enquiries cloud FY26.NAH
Trading update - Higher H1 profit and cash flow offset subdued case management in Critical Care.NAH
Trading update - Critical Care growth and lower debt cushioned Personal Injury market weakness.NAH
H1 2024 - Underlying PBT more than doubled as Critical Care grew and net debt declined despite PI market headwinds.NAH
H2 2024 - FY2025 profit and cash surged, but lower settlements may constrain 2026 cash flow.NAH
H2 2025 - Profit and cash grew in H1; settlement lifts guidance as net cash is targeted by end-October.NAH
H1 2026